The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes

American Journal of Hematology - United States
doi 10.1002/ajh.25114
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2011English

Myelodysplastic Syndromes: Histopathology as Prognostic Factor

Revista Brasileira de Hematologia e Hemoterapia
2001English

Lenalidomide: Targeted Anemia Therapy for Myelodysplastic Syndromes

Cancer Control
MedicineOncologyHematology
2006English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Impact of Clone Size With a Single Cytogenetic Abnormality on the Revised International Prognostic Scoring System in Myelodysplastic Syndromes

American Journal of Hematology
Hematology
2018English

Prognostic Role of TET2 Deficiency in Myelodysplastic Syndromes: A Meta-Analysis

Oncotarget
Oncology
2017English

Improving Prognostic Tools for Patients With Myelodysplastic Syndromes

Mayo Clinic Proceedings
Medicine
2018English

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy